Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Birchmeier, Walter Prof. Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (1) Daniel, Peter Prof. Dr. (1) Daumke, Oliver Prof. Dr. (1) Grossmann, Katja Dr. (1) Mathas, Stephan Dr. (12) Pezzutto, Antonio Prof. Dr. (1) Wollert-Wulf, Brigitte (2) (-) Janz, Martin Dr. (11) (-) Lusatis, Simone (1) (-) Selbach, Matthias Prof. Dr. (11) (-) Biologie maligner Lymphome (11) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (1) Genetik und Genomik von Herz- Kreislauferkrankungen (2) Molekulare Herz- Kreislaufforschung (1) Molekulare Immunologie und Gentherapie (1) (-) Proteom Dynamik (11) Strukturbiologie Membran-assoziierter Prozesse (1) Translationale Onkologie solider Tumore (106) 1999 (3) 2000 (1) 2001 (3) 2002 (4) 2003 (4) (-) 2004 (4) 2005 (6) (-) 2006 (6) (-) 2007 (3) 2008 (5) (-) 2009 (9) 2010 (4) 2011 (11) 2012 (6) 2013 (6) 2014 (13) 2015 (12) 2016 (9) 2017 (9) 2018 (7) 2019 (5) 2020 (10) 2021 (15) 2022 (14) 2023 (10) 2024 (3) 22 Ergebnisse: Active Filter: Janz, Martin Dr.Lusatis, SimoneSelbach, Matthias Prof. Dr.Biologie maligner LymphomeProteom Dynamik2004200620072009 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. April 2007 / Leukemia Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin/Reed-Sternberg cells M. Janz T. Stuehmer L.T. Vassilev R.C. Bargou 01. Mai 2007 / Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas 29. Oktober 2009 / Blood C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells R. Pal M. Janz D.L. Galson M. Gries S. Li K. Johrens I. Anagnostopoulos B. Doerken M.Y. Mapara L. Borghesi L. Kardava G.D. Roodman C. Milcarek S. Lentzsch 01. September 2009 / Dtsch Med Wochenschr Die molekulare Pathogenese des klassischen Hodgkin-Lymphoms [The molecular pathogenesis of classical Hodgkin lymphoma] S. Mathas B. Doerken M. Janz 01. Dezember 2009 / Curr Opin Cell Biol Quantitative proteomics: a tool to assess cell differentiation M. Vermeulen M. Selbach 29. September 2009 / Proc Natl Acad Sci U S A The tyrosine phosphatase Shp2 (PTPN11) directs neuregulin-1/ErbB signaling throughout schwann cell development K.S. Grossmann H. Wende F.E. Paul C. Cheret A.N. Garratt S. Zurborg K. Feinberg D. Besser H. Schulz E. Peles M. Selbach W. Birchmeier C. Birchmeier Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. April 2007 / Leukemia Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin/Reed-Sternberg cells M. Janz T. Stuehmer L.T. Vassilev R.C. Bargou
01. Mai 2007 / Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas
29. Oktober 2009 / Blood C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells R. Pal M. Janz D.L. Galson M. Gries S. Li K. Johrens I. Anagnostopoulos B. Doerken M.Y. Mapara L. Borghesi L. Kardava G.D. Roodman C. Milcarek S. Lentzsch
01. September 2009 / Dtsch Med Wochenschr Die molekulare Pathogenese des klassischen Hodgkin-Lymphoms [The molecular pathogenesis of classical Hodgkin lymphoma] S. Mathas B. Doerken M. Janz
01. Dezember 2009 / Curr Opin Cell Biol Quantitative proteomics: a tool to assess cell differentiation M. Vermeulen M. Selbach
29. September 2009 / Proc Natl Acad Sci U S A The tyrosine phosphatase Shp2 (PTPN11) directs neuregulin-1/ErbB signaling throughout schwann cell development K.S. Grossmann H. Wende F.E. Paul C. Cheret A.N. Garratt S. Zurborg K. Feinberg D. Besser H. Schulz E. Peles M. Selbach W. Birchmeier C. Birchmeier